InsiderTrades

Form 4 for IONS IONIS PHARMACEUTICALS INC

Accepted 2024-01-18 00:00:00 ET · period of report 2024-01-16 · accession 0000874015-24-000073 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-18 2024-01-16 IONS BENNETT C FRANK EVP, CSO M - OptEx $0.00 +18.3K 84.1K +28% $0
D 2024-01-18 2024-01-17 IONS BENNETT C FRANK EVP, CSO S - Sale+OE $50.42 -6,745 77.3K -8% -$340.1K
D 2024-01-18 2024-01-16 IONS BENNETT C FRANK EVP, CSO M - OptEx $0.00 -18.3K 23.5K -44% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-16 M A 18,314 $0.00 84,068 D — — (F1) Acquired pursuant to vesting and release of shares in accordance with Restricted Stock Unit awards.
2 Common Common Stock 2024-01-17 S D 6,745 $50.42 77,323 D — — (F2) The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice. (F3) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.35 to $50.43, inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) of this Form 4.
3 Derivative Restricted Stock Unit 2024-01-16 M D 18,314 $0.00 23,500 D $0.00 · — to — 18,314 Common Stock (F4) Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. (F5) Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.